Ceftriaxone Sulbactam for Injection Cefort-TZ

PRODUCT NAME : Ceftriaxone Sulbactam for Injection Cefort-TZ

Dosage Form: Injection

Packing: Vial

Cefort-TZ 1.125 gm by Biomorph Lifesciences is a combination of Ceftriaxone 1000 mg and Tazobactam 125 mg, formulated to provide broad-spectrum antibacterial activity against susceptible bacterial infections. Ceftriaxone is a third-generation cephalosporin antibiotic that works by interfering with bacterial cell-wall synthesis, while Tazobactam is a beta-lactamase inhibitor that helps protect Ceftriaxone from certain bacterial enzymes that can contribute to antibiotic resistance. Together, this combination provides enhanced antibacterial activity against a range of susceptible microorganisms.

Cefort-TZ 1.125 gm is intended for administration by qualified healthcare professionals and may be prescribed for the management of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, bone and joint infections, gynecological infections, and other susceptible bacterial infections where this combination is clinically appropriate. The medicine should be administered only under the guidance of a registered medical practitioner.

At Biomorph Lifesciences, Cefort-TZ 1.125 gm is manufactured using quality-focused manufacturing processes and stringent quality control standards in WHO-GMP-compliant facilities. We offer this product for PCD Pharma Franchise and Third-Party Manufacturing opportunities across India, providing reliable manufacturing support, secure packaging, timely supply, and consistent quality to help pharmaceutical businesses expand their product portfolio with confidence.

Category:

Description

MORE DETAILS ABOUT PRODUCT

Cefort-TZ 1.125 gm

  • Primary Use: Used under medical supervision for the treatment of susceptible bacterial infections.
  • How It Works: Ceftriaxone interferes with bacterial cell-wall synthesis, while Tazobactam inhibits certain beta-lactamase enzymes that may reduce the activity of beta-lactam antibiotics.
  • Antibacterial Activity: The combination provides antibacterial activity against a range of susceptible microorganisms when clinically appropriate.
  • Possible Applications: May be prescribed for respiratory tract, urinary tract, skin and soft tissue, intra-abdominal, bone and joint, and other susceptible bacterial infections.
  • Administration: Cefort-TZ 1.125 gm should be administered by a qualified healthcare professional according to the prescribed dose and route.
  • Precautions: Inform the healthcare professional about any previous allergy to Ceftriaxone, cephalosporins, penicillins, or other beta-lactam antibiotics.